Review of prognostic factors for kidney transplant survival. 2023

Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
Department of Public Health, Astana Medical University, Astana, Republic of Kazakhstan.

Transplantation is the most effective treatment for end-stage chronic kidney disease, as this procedure prolongs and improves the patient's quality of life. One of the key problems is the risk of graft rejection. The purpose of this research was to identify and analyse prognostic factors that will prevent rejection. In particular, the prognostic factors grouped by methods of synthesis, generalisation and statistical processing with calculation and graphical representation of hazard ratio and correlation coefficient were grouped, namely: age of donor and recipient, time of cold kidney ischaemia, duration of preoperative dialysis, body mass index, presence of concomitant diseases (diabetes mellitus, hypertension), primary causes causing transplantation. Several molecular genetic and biochemical prognostic markers (transcription factors, immunocompetent cell signalling and receptors, cytostatin C, creatinine, citrate, lactate, etc.) are annotated. It has been demonstrated that creatinine reduction rate determines the risk of rejection, displaying the dynamics of cystatin C and creatinine changes in the postoperative period. Young recipients who underwent prolonged preoperative dialysis were identified as having the highest risk of rejection. Diabetes and hypertension bear a non-critical but commensurately equal risk of rejection. The survival rate of the graft is better when transplanted from a living donor than from a deceased donor. A correlation between cold ischaemia time, body mass index and the probability of graft failure has been proven, namely, the greater the donor and recipient body mass index and the longer the cold ischaemia time, the lower the chance of successful long-term organ acclimation. The data obtained can be used as prognostic factors for graft accommodation at different intervals after surgery.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
February 2022, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
January 2014, Transplantation research,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
January 1986, Clinical transplants,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
November 2005, Transplantation proceedings,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
May 2014, Annals of transplantation,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
December 2018, Surgical oncology,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
January 1986, Clinical transplants,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
April 1977, Revista do Hospital das Clinicas,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
July 2005, Kidney international,
Nargiz Zulkhash, and Nasrulla Shanazarov, and Saule Kissikova, and Guldauren Kamelova, and Gulzhaina Ospanova
May 2024, Statistics in medicine,
Copied contents to your clipboard!